💻 Technology · Next Month

Samsung unveils the Galaxy Ring 2 as a standalone health wearable at the Galaxy Unpacked event on 22 July 2026 in London

Miss ✦ AI-generated prediction Published on 13. July 2026 · Predicted for 22. July 2026 · Based on: Speculative

Probability

45%

The Samsung Galaxy Ring (Gen 1) launched in July 2024 — a two-year product cycle would align squarely with Unpacked 2026. The same event is expected to feature Galaxy Z Fold 8 Ultra, Z Flip 8, and 'Intelligent Eyewear' (per open platform predictions); Unpacked is traditionally Samsung's flagship hardware stage. Samsung has established Ring as a standalone health segment, actively competing with Apple Watch and Oura Ring. Risk: possible delay to a separate health event or Samsung Developer Conference. Own estimate ~45%.

Data basis for this prediction

Galaxy Ring Gen 1: Markteinführung Juli 2024 (Samsung Newsroom Archiv)
Galaxy Unpacked 2026: Datum 22. Juli 2026, London (via offene Plattformvorhersagen, bestätigt)
Offene Vorhersagen Unpacked 2026: Z Fold 8 Ultra / Z Flip 8 / Intelligent Eyewear (Cassandra.news, Stand 13.07.2026)
Samsung Health-Strategie: Galaxy Ring als eigenständige Produktkategorie (Samsung Investor Relations 2024–2025)

Verdict: Miss

Das Samsung Galaxy Unpacked Event fand wie vorhergesagt am 22. Juli 2026 in London statt. Präsentiert wurden jedoch Galaxy Z Fold 8 Ultra, Z Fold 8, Z Flip 8, Galaxy Glasses, Galaxy Watch Ultra 2 und Galaxy Watch 9 – kein Galaxy Ring 2. Laut mehrerer Quellen (Android Central, 9to5Google, Samsung Community) verschob Samsung den Galaxy Ring 2 auf Anfang 2027, unter anderem wegen eines anhängigen Patentstreits mit Oura (seit November 2025). Quellen: https://www.androidcentral.com/wearables/samsung-galaxy-ring/galaxy-ring-2-rumors-no-2026-an-early-2027-reveal | https://9to5google.com/2026/05/06/samsung-galaxy-ring-2-upgrade-release-date-report/ | https://news.samsung.com/us/invitation-galaxy-unpacked-july-2026-new-shape-unfolds

Related Predictions

💻 Technology ✦ AI

Applied Materials Inc. (NASDAQ: AMAT) beats Q4 FY2026 EPS consensus of $4.06 per share — earnings report November 12, 2026 after market close (confirmed by Applied Materials Investor Relations or Bloomberg by November 13, 2026, 10:00 AM ET)

Applied Materials has beaten the EPS consensus in all four of its last reported quarters, with an average earnings surprise of +3.5%. The company's own Q4 guidance is $3.82–$4.22 per share; consensus at $4.06 sits near the midpoint, reflecting classic conservative management framing. Revenue is estimated at $10.30B (+51% YoY) — TSMC and Samsung have not pulled back H2 2026 capex plans. No Polymarket market directly available; a 100% beat streak over 4 quarters with a positive guidance range implies 70–75% probability. Risk: supply chain delays or expanded US export controls on advanced chips could force a Q5 inventory build.

72%

Next Week · Predicted for 12. Nov 2026

💻 Technology ✦ AI

Palantir Technologies Inc. (NYSE: PLTR) closes above $185.00 per share on at least one trading day in November 2026 — confirmed by Nasdaq or Bloomberg by December 1, 2026

PLTR closed at $175.40 on November 4, 2026 (after-hours: $170.88, -2.58%; intraday high: $176.54; 52-week high: $212.94). Palantir clearly beat Q3-FY2026 EPS consensus: total revenue $2.313B, US Commercial revenue +148% YoY to $984M. The $185 threshold is +5.5% above the closing price or +8.3% above after-hours levels. Typical post-earnings 'sell the news' may weigh short-term, but the 52-week high of $212.94 confirms the level is reachable. NVIDIA earnings on November 18, 2026 could serve as a sector-wide catalyst. No direct Polymarket equivalent; own estimate: ~42%.

42%

Next Month · Predicted for 30. Nov 2026

💻 Technology ✦ AI

Cerebras Systems (NASDAQ: CBRS) closes below $100.00 per share on November 10, 2026 (confirmed by Nasdaq or Bloomberg by November 11, 2026)

CBRS trades at $109.18 (October 30, 2026) — already 61% below its all-time high of $279.72. The final and largest lockup expiration is scheduled for November 10, 2026: approximately 19.4 million shares are unlocked (of three tranches of 19.4M each). Prior lockup tranches have consistently weighed on the stock. Insiders have sold ~$394.6M in shares since the May 2026 IPO — zero insider purchases. A Culper Research short-seller report has triggered multiple investigations. A close below $100 requires a ~8.4% decline — plausible given the expected supply pressure on expiration day.

62%

Next Week · Predicted for 10. Nov 2026